Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 1
2006 4
2007 3
2008 1
2010 2
2011 6
2012 6
2013 1
2014 2
2017 2
2018 1
2019 4
2020 5
2021 8
2022 10
2023 7
2024 3
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
Effect of the glucagon-like peptide-1 receptor agonist liraglutide, compared to caloric restriction, on appetite, dietary intake, body fat distribution and cardiometabolic biomarkers: A randomized trial in adults with obesity and prediabetes.
Silver HJ, Olson D, Mayfield D, Wright P, Nian H, Mashayekhi M, Koethe JR, Niswender KD, Luther JM, Brown NJ. Silver HJ, et al. Diabetes Obes Metab. 2023 Aug;25(8):2340-2350. doi: 10.1111/dom.15113. Epub 2023 May 15. Diabetes Obes Metab. 2023. PMID: 37188932 Free PMC article. Clinical Trial.
Fractional coalescent.
Mashayekhi S, Beerli P. Mashayekhi S, et al. Proc Natl Acad Sci U S A. 2019 Mar 26;116(13):6244-6249. doi: 10.1073/pnas.1810239116. Epub 2019 Mar 13. Proc Natl Acad Sci U S A. 2019. PMID: 30867282 Free PMC article.
Comparative effects of weight loss and incretin-based therapies on vascular endothelial function, fibrinolysis and inflammation in individuals with obesity and prediabetes: A randomized controlled trial.
Mashayekhi M, Beckman JA, Nian H, Garner EM, Mayfield D, Devin JK, Koethe JR, Brown JD, Cahill KN, Yu C, Silver H, Niswender K, Luther JM, Brown NJ. Mashayekhi M, et al. Diabetes Obes Metab. 2023 Feb;25(2):570-580. doi: 10.1111/dom.14903. Epub 2022 Nov 10. Diabetes Obes Metab. 2023. PMID: 36306151 Free PMC article. Clinical Trial.
Population Genetic Inference With MIGRATE.
Beerli P, Mashayekhi S, Sadeghi M, Khodaei M, Shaw K. Beerli P, et al. Curr Protoc Bioinformatics. 2019 Dec;68(1):e87. doi: 10.1002/cpbi.87. Curr Protoc Bioinformatics. 2019. PMID: 31756024 Free PMC article.
Immune Cell Activation in Obesity and Cardiovascular Disease.
Garcia JN, Wanjalla CN, Mashayekhi M, Hasty AH. Garcia JN, et al. Curr Hypertens Rep. 2022 Dec;24(12):627-637. doi: 10.1007/s11906-022-01222-4. Epub 2022 Sep 22. Curr Hypertens Rep. 2022. PMID: 36136214 Free PMC article. Review.
The subcutaneous adipose transcriptome identifies a molecular signature of insulin resistance shared with visceral adipose.
Mashayekhi M, Sheng Q, Bailin SS, Massier L, Zhong J, Shi M, Wanjalla CN, Wang TJ, Ikizler TA, Niswender KD, Gabriel CL, Palacios J, Turgeon-Jones R, Reynolds CF, Luther JM, Brown NJ, Das S, Dahlman I, Mosley JD, Koethe JR, Rydén M, Bachmann KN, Shah RV. Mashayekhi M, et al. Obesity (Silver Spring). 2024 Aug;32(8):1526-1540. doi: 10.1002/oby.24064. Epub 2024 Jul 5. Obesity (Silver Spring). 2024. PMID: 38967296 Free PMC article.
Association of SARS-CoV-2 infection with neurological impairments in pediatric population: A systematic review.
Kwan ATH, Portnoff JS, Al-Kassimi K, Singh G, Hanafimosalman M, Tesla M, Gharibi N, Ni T, Guo Z, Sonfack DJN, Martyniuk J, Arfaie S, Mashayekhi MS, Mofatteh M, Jeremian R, Ho K, Moscote-Salazar LR, Lee Á, Jawad MY, Ceban F, Teopiz KM, Mansur RB, Ho R, Rosenblat JD, Cao B, Rhee TG, McIntyre RS. Kwan ATH, et al. J Psychiatr Res. 2024 Feb;170:90-110. doi: 10.1016/j.jpsychires.2023.12.005. Epub 2023 Dec 11. J Psychiatr Res. 2024. PMID: 38134724
Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations.
Ybarra LF, Rinfret S, Brilakis ES, Karmpaliotis D, Azzalini L, Grantham JA, Kandzari DE, Mashayekhi K, Spratt JC, Wijeysundera HC, Ali ZA, Buller CE, Carlino M, Cohen DJ, Cutlip DE, De Martini T, Di Mario C, Farb A, Finn AV, Galassi AR, Gibson CM, Hanratty C, Hill JM, Jaffer FA, Krucoff MW, Lombardi WL, Maehara A, Magee PFA, Mehran R, Moses JW, Nicholson WJ, Onuma Y, Sianos G, Sumitsuji S, Tsuchikane E, Virmani R, Walsh SJ, Werner GS, Yamane M, Stone GW, Rinfret S, Stone GW; Chronic Total Occlusion Academic Research Consortium. Ybarra LF, et al. Circulation. 2021 Feb 2;143(5):479-500. doi: 10.1161/CIRCULATIONAHA.120.046754. Epub 2021 Feb 1. Circulation. 2021. PMID: 33523728
58 results